AbbVie Inc. is 373.3x more valuable than Savara Inc by market capitalization ($402.35 B vs $1.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SVRA | ABBV |
|---|---|---|
| Market cap | $1.08 B | $402.35 B |
| US-listed rank | #2597 | #31 |
| Revenue (latest FY) | $257.00K | $61.16B |
| Net income (latest FY) | -$118.84M | $4.23B |
| Net margin | -46240.1% | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 1,331 | 1,008 |
AbbVie Inc. is 373.3x more valuable than Savara Inc by market capitalization ($402.35 B vs $1.08 B).
Full pages: Savara Inc and AbbVie Inc., or browse the full rankings.